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Abstract
We report on three Caucasian Greeks 2 males and 1 female (67, 54 and 62 years old) that were
operated with sarcomatoid carcinoma of the lung, an uncommon tumor that sometimes is referred as
pleomorphic carcinoma (spindle and giant cell carcinomas). These tumors are encountered in the
thorax far more often than true sarcomas. There are many erroneous reports of pulmonary
sarcomas made before the advent of adjunctive pathologic screening, including immunohistochemical
studies. Pulmonary Sarcomatoid Carcinomas represent 0.2-1% of all lung cancers in different series
and they are considered that they are not significantly aggressive than ordinary lung carcinoma.
Introduction
Sarcomatoid carcinomas (SC) of the lung (spindle and
giant cell carcinomas) are rare histologic subtypes and
have been reported as having a poor prognosis. In the
World Health Organization (WHO) histologic classifica-
tion of lung tumors, spindle cell carcinoma is classified as
a variant of squamous cell carcinoma and giant cell
carcinoma is classified as a variant of large cell carcinoma.
Fishback et al. designated sarcomatoid carcinomas as
pleomorphic (spindle/giant cell) carcinomas of the lung
because both spindle and giant cell components are often
found in the same tumors [1].
Case presentation
Since 1990 three Caucasian Greeks 2 male and 1 female
(67, 54 and 62 years old) were operated at the Department
of Thoracic and Cardiovascular Surgery at Athens Naval
and Veterans Hospital with a final diagnosis of SC. All
had a history of cigarette smoking (60, 45, 25 pack/years
respectively) and social alcohol drinking but without
significant medical or family history. All three had a
normal weight for their height. The male patients were
former shipyard workers and the female an office worker.
Presenting symptoms were cough, hemoptysis and atypi-
cal chest discomfort. In one case, the presenting symptom
was diarrhea. Two of the tumors were in the right upper
lobe and one case in left lower lobe. All of the patients had
a complete pre-operative staging with CT scans, broncho-
scopy and radioisotopic studies of the body. FNA cytologic
examination revealed non-small cell lung cancer.
Right pneumonectomy, right upper lobectomy and left
lower lobectomy were performed respectively with med-
iastinal lymph node dissection, which revealed N2 disease
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in one case. All 3 patients received postoperative
chemotherapy and radiation as a part of an adjuvant
therapy in their management.
Immunohistochemical studies were performed by the
avidin-biotin-peroxidase complex method. Spindle cell
type was comprised of fusiform malignant cells that were
positively reactive to one or more epithelial markers
including cytokeratins, carcinoembryonic antigen, and
epithelial membrane antigen. Giant cell type was com-
prised of tumor giant cells with abundant cytoplasm and
multiple nuclei or a single large pleomorphic nucleus.
The mixed type exhibit a mixture of spindle cell type and
giant cell type, each of which comprised ≥25% of the
sarcomatoid areas. Histology of these specimens was
diagnostic for sarcomatoid carcinomas of the lung of
giant cell type in one patient and spindle cell type in two,
using immunohistochemical studies. One of the patients
(male 67 years old) is still alive 21 months after the
operation. The other two died 7 months and 12 months
after the operation, respectively, from distant metastases to
liver and contalateral lung respectively.
Discussion
Sarcomatoid carcinomas (SC) of the lung are a hetero-
geneous group of non-small cell lung carcinomas
(NSCLC) containing a sarcoma or sarcoma-like compo-
nent. SCmay represent an epithelial neoplasm undergoing
divergent tissue differentiation originating from a single
clone. These tumors are the most common pulmonary
neoplasms that exhibit a composition by spindled or
pleomorphic tumor cells. As such, many of them may be
confused easily with true sarcomas diagnostically unless
special immunohistological or ultrastructural analyses are
performed. Accurate diagnostic workup is crucial for the
management of these uncommon tumors [2].
Reactivity is expected for keratin, epithelial membrane
antigen, or collagen type IV in the sarcoma-like elements in
SC, although it may be focal. Electron microscopy often
shows the presence of junctional complexes between
tumor cells, with or without pericellular basal lamina
and cytoplasmic skeins of intermediate filaments.
Current terminological preferences are such that several
formerly used terms–including “spindle-cell carcinoma,”
“pulmonary blastoma,” “squamous cell carcinoma with
pseudosarcomatous stroma,” “pseudosarcoma,” and
“carcinosarcoma”–are now encompassed by the more
generic designation of “sarcomatoid carcinoma.” The
clinical course of patients with this neoplasm is aggressive,
with an overall 5-year survival rate approximating 20% [3].
With regard to the origin of neoplastic spindle and giant
cells, three hypotheses can be considered. First, carcinoma
cells change into neoplastic spindle and giant cells and
these cells still are carcinoma. This idea is supported by
many investigators because the transition of carcinoma
cells into spindle cells occasionally is recognized. Second,
although these cells originate from carcinoma, they obtain
mesenchymal differentiation and change into true sar-
coma. Third, these cells originate from sarcoma and
differentiate into carcinoma [1].
Although sarcomatoid carcinomas are generally believed
to be more aggressive and have a poorer prognosis than
ordinary lung carcinomas, no statistical analysis has been
reported. Except for the report from the Armed Forces
Institute of Pathology by Fishback et al. 2 They reported
that tumor size > 5 cm, a clinical Stage > Stage I, and lymph
node involvement shortened patient survival, signifi-
cantly. The median survival of patients with sarcomatoid
carcinoma was 10 months, which, when compared with
that of ordinary lung carcinomas in the literature (20
months for adenocarcinoma, 18.5 months for squamous
cell carcinoma, and 12.6 months for large cell carcinoma),
was brief. However, in the current study as in our case
series there was no significant difference between the
prognosis of patients with sarcomatoid carcinoma and
that of patients with nonsarcomatoid, non-small cell
carcinoma of the lung [4].
As in every non-small cell lung cancer, early detection,
accurate diagnosis and an aggressive operative manage-
ment is the mainstay of the best chances of long-term
survival in these unusual tumors of the lung. The role of
adjuvant or neo-adjuvant chemoradiotherapy has not
been proved beneficial alone, but they play an important
role as an adjunct to standard accepted operative
treatment.
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